Literature DB >> 15931596

Germline susceptibility to colorectal cancer due to base-excision repair gene defects.

Susan M Farrington1, Albert Tenesa, Rebecca Barnetson, Alice Wiltshire, James Prendergast, Mary Porteous, Harry Campbell, Malcolm G Dunlop.   

Abstract

DNA repair is a key process in the maintenance of genome integrity. Here, we present a large, systematically collected population-based association study (2,239 cases; 1,845 controls) that explores the contribution to colorectal cancer incidence of inherited defects in base-excision repair (BER) genes. We show that biallelic MUTYH defects impart a 93-fold (95% CI 42-213) excess risk of colorectal cancer, which accounts for 0.8% of cases aged <55 years and 0.54% of the entire cohort. Penetrance for homozygous carriers was almost complete by age 60 years. Significantly more biallelic carriers had coexisting adenomatous polyps. However, notably, 36% of biallelic carriers had no polyps. Three patients with heterozygous MUTYH defects carried monoallelic mutations in other BER genes (OGG1 and MTH1). Recessive inheritance accounted for the elevated risk for those aged <55 years. However, there was also a 1.68-fold (95% CI 1.07-2.95) excess risk for heterozygous carriers aged >55 years, with a population attributable risk in this age group of 0.93% (95% CI 0%-2.0%). These data provide the strongest evidence to date for a causative role of BER defects in colorectal cancer etiology and show, to our knowledge for the first time, that heterozygous MUTYH mutations predispose to colorectal cancer later in life. These findings have clinical relevance for BER gene testing for patients with colorectal cancer and for genetic counseling of their relatives.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15931596      PMCID: PMC1226182          DOI: 10.1086/431213

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  10 in total

1.  The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Authors:  J M Satagopan; K Offit; W Foulkes; M E Robson; S Wacholder; C M Eng; S E Karp; C B Begg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-05       Impact factor: 4.254

2.  Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.

Authors:  Nada Al-Tassan; Nikolas H Chmiel; Julie Maynard; Nick Fleming; Alison L Livingston; Geraint T Williams; Angela K Hodges; D Rhodri Davies; Sheila S David; Julian R Sampson; Jeremy P Cheadle
Journal:  Nat Genet       Date:  2002-01-30       Impact factor: 38.330

3.  Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.

Authors:  Oliver M Sieber; Kimberley M Howarth; Christina Thirlwell; Andrew Rowan; Nikki Mandir; Robert A Goodlad; Ashfaq Gilkar; Bradley Spencer-Dene; Gordon Stamp; Victoria Johnson; Andrew Silver; Hanjing Yang; Jeffrey H Miller; Mohammad Ilyas; Ian P M Tomlinson
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

4.  Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk.

Authors:  Marina E Croitoru; Sean P Cleary; Nando Di Nicola; Michael Manno; Teresa Selander; Melyssa Aronson; Mark Redston; Michelle Cotterchio; Julia Knight; Robert Gryfe; Steven Gallinger
Journal:  J Natl Cancer Inst       Date:  2004-11-03       Impact factor: 13.506

5.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

6.  Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.

Authors:  Oliver M Sieber; Lara Lipton; Michael Crabtree; Karl Heinimann; Paulo Fidalgo; Robin K S Phillips; Marie-Luise Bisgaard; Torben F Orntoft; Lauri A Aaltonen; Shirley V Hodgson; Huw J W Thomas; Ian P M Tomlinson
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

7.  Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH.

Authors:  Julian R Sampson; Sunil Dolwani; Sian Jones; Diana Eccles; Anthony Ellis; D Gareth Evans; Ian Frayling; Sheila Jordan; Eamonn R Maher; Tony Mak; Julie Maynard; Francesca Pigatto; Joan Shaw; Jeremy P Cheadle
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

8.  Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients.

Authors:  Susa Enholm; Tuija Hienonen; Anu Suomalainen; Lara Lipton; Ian Tomlinson; Vesa Kärjä; Matti Eskelinen; Jukka-Pekka Mecklin; Auli Karhu; Heikki J Järvinen; Lauri A Aaltonen
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps.

Authors:  Liang Wang; Linnea M Baudhuin; Lisa A Boardman; Kelle J Steenblock; Gloria M Petersen; Kevin C Halling; Amy J French; Ruth A Johnson; Lawrence J Burgart; Kari Rabe; Noralane M Lindor; Stephen N Thibodeau
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

10.  Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer.

Authors:  Christina Fleischmann; Julian Peto; Jeremy Cheadle; Bindiya Shah; Julian Sampson; Richard S Houlston
Journal:  Int J Cancer       Date:  2004-04-20       Impact factor: 7.396

  10 in total
  81 in total

1.  MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer.

Authors:  María Dolores Giráldez; Francesc Balaguer; Luis Bujanda; Miriam Cuatrecasas; Jenifer Muñoz; Virginia Alonso-Espinaco; Mikel Larzabal; Anna Petit; Victoria Gonzalo; Teresa Ocaña; Leticia Moreira; José María Enríquez-Navascués; C Richard Boland; Ajay Goel; Antoni Castells; Sergi Castellví-Bel
Journal:  Clin Cancer Res       Date:  2010-10-05       Impact factor: 12.531

2.  Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis.

Authors:  Aung Ko Win; John L Hopper; Mark A Jenkins
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

Review 3.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

4.  Colorectal cancer risk in monoallelic carriers of MYH variants.

Authors:  Emily L Webb; Mathew F Rudd; Richard S Houlston
Journal:  Am J Hum Genet       Date:  2006-10       Impact factor: 11.025

5.  MYH, OGG1, MTH1, and APC alterations involved in the colorectal tumorigenesis of Korean patients with multiple adenomas.

Authors:  Jin C Kim; In H Ka; Yoo M Lee; Kum H Koo; Hee C Kim; Chang S Yu; Se J Jang; Yong S Kim; Han I Lee; Kang H Lee
Journal:  Virchows Arch       Date:  2007-01-25       Impact factor: 4.064

Review 6.  Base-excision repair of oxidative DNA damage.

Authors:  Sheila S David; Valerie L O'Shea; Sucharita Kundu
Journal:  Nature       Date:  2007-06-21       Impact factor: 49.962

Review 7.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

Review 8.  The differential diagnosis and surveillance of hereditary gastrointestinal polyposis syndromes.

Authors:  Stefan Aretz
Journal:  Dtsch Arztebl Int       Date:  2010-03-12       Impact factor: 5.594

9.  Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21.

Authors:  Albert Tenesa; Susan M Farrington; James G D Prendergast; Mary E Porteous; Marion Walker; Naila Haq; Rebecca A Barnetson; Evropi Theodoratou; Roseanne Cetnarskyj; Nicola Cartwright; Colin Semple; Andrew J Clark; Fiona J L Reid; Lorna A Smith; Kostas Kavoussanakis; Thibaud Koessler; Paul D P Pharoah; Stephan Buch; Clemens Schafmayer; Jürgen Tepel; Stefan Schreiber; Henry Völzke; Carsten O Schmidt; Jochen Hampe; Jenny Chang-Claude; Michael Hoffmeister; Hermann Brenner; Stefan Wilkening; Federico Canzian; Gabriel Capella; Victor Moreno; Ian J Deary; John M Starr; Ian P M Tomlinson; Zoe Kemp; Kimberley Howarth; Luis Carvajal-Carmona; Emily Webb; Peter Broderick; Jayaram Vijayakrishnan; Richard S Houlston; Gad Rennert; Dennis Ballinger; Laura Rozek; Stephen B Gruber; Koichi Matsuda; Tomohide Kidokoro; Yusuke Nakamura; Brent W Zanke; Celia M T Greenwood; Jagadish Rangrej; Rafal Kustra; Alexandre Montpetit; Thomas J Hudson; Steven Gallinger; Harry Campbell; Malcolm G Dunlop
Journal:  Nat Genet       Date:  2008-03-30       Impact factor: 38.330

Review 10.  Serrated pathway colorectal cancer in the population: genetic consideration.

Authors:  Joanne Young; Mark Jenkins; Susan Parry; Bruce Young; Derek Nancarrow; Dallas English; Graham Giles; Jeremy Jass
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.